Rivus Pharma

Rivus Pharmaceuticals develops Controlled Metabolic Accelerators for obesity and cardiometabolic disorders, targeting mitochondrial respiration.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2022